Charles River Laboratories Pre-Tax Income 2010-2024 | CRL

Charles River Laboratories annual/quarterly pre-tax income history and growth rate from 2010 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
  • Charles River Laboratories pre-tax income for the quarter ending September 30, 2024 was $0.091B, a 19.16% decline year-over-year.
  • Charles River Laboratories pre-tax income for the twelve months ending September 30, 2024 was $0.519B, a 16.01% decline year-over-year.
  • Charles River Laboratories annual pre-tax income for 2023 was $0.581B, a 6.69% decline from 2022.
  • Charles River Laboratories annual pre-tax income for 2022 was $0.623B, a 29.6% increase from 2021.
  • Charles River Laboratories annual pre-tax income for 2021 was $0.481B, a 7.51% increase from 2020.
Charles River Laboratories Annual Pre-Tax Income
(Millions of US $)
2023 $581
2022 $623
2021 $481
2020 $447
2019 $304
2018 $282
2017 $297
2016 $223
2015 $195
2014 $178
2013 $138
2012 $130
2011 $133
2010 $-334
2009 $152
Charles River Laboratories Quarterly Pre-Tax Income
(Millions of US $)
2024-09-30 $91
2024-06-30 $120
2024-03-31 $99
2023-12-31 $209
2023-09-30 $113
2023-06-30 $129
2023-03-31 $131
2022-12-31 $245
2022-09-30 $123
2022-06-30 $144
2022-03-31 $111
2021-12-31 $164
2021-09-30 $123
2021-06-30 $127
2021-03-31 $66
2020-12-31 $172
2020-09-30 $135
2020-06-30 $84
2020-03-31 $55
2019-12-31 $106
2019-09-30 $73
2019-06-30 $59
2019-03-31 $66
2018-12-31 $75
2018-09-30 $73
2018-06-30 $70
2018-03-31 $63
2017-12-31 $69
2017-09-30 $73
2017-06-30 $77
2017-03-31 $78
2016-12-31 $64
2016-09-30 $53
2016-06-30 $54
2016-03-31 $52
2015-12-31 $50
2015-09-30 $53
2015-06-30 $60
2015-03-31 $32
2014-12-31 $40
2014-09-30 $44
2014-06-30 $51
2014-03-31 $43
2013-12-31 $23
2013-09-30 $43
2013-06-30 $37
2013-03-31 $36
2012-12-31 $26
2012-09-30 $28
2012-06-30 $40
2012-03-31 $35
2011-12-31 $33
2011-09-30 $25
2011-06-30 $43
2011-03-31 $33
2010-12-31 $-373
2010-09-30 $-8
2010-06-30 $22
2010-03-31 $24
2009-12-31 $29
2009-09-30 $40
2009-06-30 $47
2009-03-31 $35
Sector Industry Market Cap Revenue
Medical Medical Services $9.516B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00